Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment.

Seripa D, Latina P, Fontana A, Gravina C, Lattanzi M, Savino M, Gallo AP, Melchionda G, Santini SA, Margaglione M, Copetti M, di Mauro L, Panza F, Greco A, Pilotto A.

Pain Med. 2015 Oct;16(10):2012-23. doi: 10.1111/pme.12778. Epub 2015 May 19.

PMID:
25989235
2.

Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs.

Savino M, Seripa D, Gallo AP, Garrubba M, D'Onofrio G, Bizzarro A, Paroni G, Paris F, Mecocci P, Masullo C, Pilotto A, Santini SA.

Clin Lab. 2011;57(11-12):887-93.

PMID:
22239018
3.

Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease.

Seripa D, Bizzarro A, Pilotto A, D'onofrio G, Vecchione G, Gallo AP, Cascavilla L, Paris F, Grandone E, Mecocci P, Santini SA, Masullo C, Pilotto A.

Pharmacogenet Genomics. 2011 Apr;21(4):225-30. doi: 10.1097/FPC.0b013e32833f984c.

PMID:
20859244
4.

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, Rossiello R, Zito F, Stefania T, Paradiso A, Carella M, Dallapiccola B, Murgo R, Carosi I, Bisceglia M, Fazio VM, Sidransky D, Parrella P.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2694-700. doi: 10.1158/1055-9965.EPI-08-0821. Epub 2009 Sep 29.

5.

High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas.

Parrella P, la Torre A, Copetti M, Valori VM, Barbano R, Notarangelo A, Bisceglia M, Gallo AP, Balsamo T, Poeta ML, Carella M, Catapano D, Parisi S, Dallapiccola B, Maiello E, D'Angelo V, Fazio VM.

J Biomed Biotechnol. 2009;2009:531692. doi: 10.1155/2009/531692. Epub 2009 Jun 1.

6.

Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.

Lopes CT, Gallo AP, Palma PV, Cury PM, Bueno V.

Transplant Proc. 2008 Apr;40(3):856-60. doi: 10.1016/j.transproceed.2008.02.051.

PMID:
18455036
7.

Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma.

Scintu M, Vitale R, Prencipe M, Gallo AP, Bonghi L, Valori VM, Maiello E, Rinaldi M, Signori E, Rabitti C, Carella M, Dallapiccola B, Altomare V, Fazio VM, Parrella P.

Cancer Lett. 2007 Sep 8;254(2):298-307. Epub 2007 May 10.

PMID:
17498870
8.

Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection.

Parrella P, Seripa D, Matera MG, Rinaldi M, Signori E, Gravina C, Gallo AP, Prencipe M, Grandone E, Mariani L, Cordiali P, Di Carlo A, Stentella P, Pachì A, Fazio VM.

Eur J Epidemiol. 2007;22(3):159-62. Epub 2007 Feb 15.

PMID:
17380431
9.

Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.

Gallo AP, Silva LB, Franco M, Burdmann EA, Bueno V.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1919-24.

PMID:
17219691
10.

Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer.

Parrella P, Mazzarelli P, Signori E, Perrone G, Marangi GF, Rabitti C, Delfino M, Prencipe M, Gallo AP, Rinaldi M, Fabbrocini G, Delfino S, Persichetti P, Fazio VM.

J Clin Pathol. 2006 Nov;59(11):1181-5. Epub 2006 Feb 23.

11.

HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.

Parrella P, Scintu M, Prencipe M, Poeta ML, Gallo AP, Rabitti C, Rinaldi M, Tommasi S, Paradiso A, Schittulli F, Valori VM, Toma S, Altomare V, Fazio VM.

Cancer Lett. 2005 May 10;222(1):75-81.

PMID:
15837543
12.

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.

Parrella P, Poeta ML, Gallo AP, Prencipe M, Scintu M, Apicella A, Rossiello R, Liguoro G, Seripa D, Gravina C, Rabitti C, Rinaldi M, Nicol T, Tommasi S, Paradiso A, Schittulli F, Altomare V, Fazio VM.

Clin Cancer Res. 2004 Aug 15;10(16):5349-54.

13.

Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2.

Parrella P, Fazio VM, Gallo AP, Sidransky D, Merbs SL.

Cancer Res. 2003 Dec 1;63(23):8507-10.

Supplemental Content

Loading ...
Support Center